Prognostic significance of preoperative fibrinogen in patients with colon cancer

Table 4 Studies on fibrinogen in different malignancies

Ref.	Country	n	Pre-therapeutic plasma fibrinogen (g/L)	Cancer type	PrognosisDFS/OS
Takeuchi et al[1] (2007)	Japan	105	3.86 ± 1.02	Esophageal cancer	No, neither
Polterauer et al[2] (2009)	Austria	313	4.17 ± 1.30	Cervical cancer	Yes, both
Polterauer et al[3] (2009)	Austria	422	4.50 ± 1.50	Ovarian cancer	Yes, both
Ghezzi et al[4] (2010)	Italy	336	hyper: 40.8%	Endometrial cancer	Yes, both
Zhao et al[5] (2012)	China	160	4.72 ± 1.46	Non-small cell lung cancer	DFS, no; OS, yes
Son et al[6] (2013)	South Korea	624	3.25 ± 0.88	Non-metastatic colon cancer	Yes, both
Zhu et al[7] (2013)	China	275	3.92 (0.68-9.80)	Non-small cell lung cancer	Yes, both

DFS: Disease-free survival; OS: Overall survival.